BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9842409)

  • 1. Cardiomyopathy due to a pheochromocytoma. A reversible entity.
    Gatzoulis KA; Tolis G; Theopistou A; Gialafos JH; Toutouzas PK
    Acta Cardiol; 1998; 53(4):227-9. PubMed ID: 9842409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phaeochromocytoma presenting as dilated cardiomyopathy.
    Attar MN; Moulik PK; Salem GD; Rose EL; Khaleeli AA
    Int J Clin Pract; 2003; 57(6):547-8. PubMed ID: 12918898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytoma underlying hypertension, stroke, and dilated cardiomyopathy.
    Lin PC; Hsu JT; Chung CM; Chang ST
    Tex Heart Inst J; 2007; 34(2):244-6. PubMed ID: 17622380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma presenting as acute severe congestive heart failure, dilated cardiomyopathy, and severe mitral valvular regurgitation: a case report and review of the literature.
    Kelley SR; Goel TK; Smith JM
    J Surg Educ; 2009; 66(2):96-101. PubMed ID: 19486873
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversible catecholamine-induced cardiomyopathy due to pheochromocytoma: case report.
    Satendra M; de Jesus C; Bordalo e Sá AL; Rosário L; Rocha J; Bicha Castelo H; Correia MJ; Nunes Diogo A
    Rev Port Cardiol; 2014 Mar; 33(3):177.e1-6. PubMed ID: 24684896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pheochromocytoma complicated with acute renal failure and cardiomyopathy.
    Hamada N; Akamatsu A; Joh T
    Jpn Circ J; 1993 Jan; 57(1):84-90. PubMed ID: 8437346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pheochromocytoma and aortocoronary bypass. Double surgical procedure].
    Vacheron A; Heulin A; Baubion N; Donne C; Jambers B; Dumas P; Delvaux JC
    Ann Med Interne (Paris); 1984; 135(4):305-7. PubMed ID: 6332567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible dilated cardiomyopathy after surgical resection of pheochromocytomas associated with von Hippel-Lindau disease.
    Mitsuma W; Ito M; Fujita S; Sato A; Washizuka T; Kodama M; Aizawa Y
    Int J Cardiol; 2009 Jan; 131(3):e95-6. PubMed ID: 17942173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension.
    Brilakis ES; Young WF; Wilson JW; Thompson GB; Munger TM
    J Heart Lung Transplant; 1999 Apr; 18(4):376-80. PubMed ID: 10226904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pheochromocytoma-induced dilated cardiomyopathy].
    Kjernsmo A
    Tidsskr Nor Laegeforen; 1991 Sep; 111(21):2640-3. PubMed ID: 1948849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart transplantation for end-stage cardiomyopathy caused by an occult pheochromocytoma.
    Wilkenfeld C; Cohen M; Lansman SL; Courtney M; Dische MR; Pertsemlidis D; Krakoff LR
    J Heart Lung Transplant; 1992; 11(2 Pt 1):363-6. PubMed ID: 1576142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of left ventricular ejection fraction following resection of pheochromocytoma in a patient with dilated cardiomyopathy.
    Hicks RJ; Wood B; Kalff V; Anderson ST; Kelly MJ
    Clin Nucl Med; 1991 Jun; 16(6):413-6. PubMed ID: 1868653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe reversible dilated cardiomyopathy in a patient with multiple endocrine neoplasia 2A syndrome.
    Gursoy A; Erdogan MF; Kamel N
    J Endocrinol Invest; 2006 Apr; 29(4):363-6. PubMed ID: 16699305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone-induced congestive heart failure in a patient with dilated cardiomyopathy caused by occult pheochromocytoma.
    Kothari SN; Kisken WA
    Surgery; 1998 Jan; 123(1):102-5. PubMed ID: 9457230
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiac failure caused by cardiomyopathy disclosing pheochromocytoma. Perioperative treatment].
    Chardigny C; Bensasson D; Couetil JP; Abastado P; Cousin MT
    Ann Cardiol Angeiol (Paris); 1994 Jan; 43(1):17-21. PubMed ID: 8172473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular event, dilated cardiomyopathy, and pheochromocytoma.
    Dagartzikas MI; Sprague K; Carter G; Tobias JD
    Pediatr Emerg Care; 2002 Feb; 18(1):33-5. PubMed ID: 11862137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial presentation of pheochromocytoma with Takotsubo cardiomyopathy: a brief review of literature.
    Gujja KR; Aslam AF; Privman V; Tejani F; Vasavada B
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):49-52. PubMed ID: 19797977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute cardiomyopathy and multiorgan failure in a patient with pheochromocytoma and neurofibromatosis type 1.
    Ahmed R; Darrat Y; Hamoudeh E; Elhamdani MO; Yaqub A
    J Pak Med Assoc; 2014 Feb; 64(2):214-6. PubMed ID: 24640818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine-provoked paradoxical pheochromocytoma crisis: a case of cardiogenic shock.
    Ferguson KL
    Am J Emerg Med; 1994 Mar; 12(2):190-2. PubMed ID: 8161395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pheochromocytoma, acute myocardial infarction and silent postprandial ischemia].
    Juncal A; Figueras J
    Rev Esp Cardiol; 1996 Jan; 49(1):73-6. PubMed ID: 8685516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.